CAMLINFINE NSE filing

Camlin Fine Sciences Files SEBI Compliance Certificate for Q3 FY26

The RealCase readLow impact Neutral

Camlin Fine Sciences Limited submitted a compliance certificate for the quarter ended December 31, 2025. The certificate from MUFG Intime India Private Limited confirms the processing of dematerialised securities and adherence to SEBI regulations.

Why it matters

This is a standard regulatory filing that is required on a quarterly basis and does not provide any new material information that would affect the company's operations or stock.

The market read

The announcement is a routine compliance filing and does not contain any new financial information or strategic developments that would impact the company's sentiment.

Camlin Fine Sciences Limited has submitted a confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025. This certificate was received from MUFG Intime India Private Limited, the company's Registrar and Share Transfer Agent.

The certificate confirms that securities received from depository participants for dematerialisation during the quarter were processed by MUFG Intime India Private Limited and confirmed to the depositories. It also states that the securities were listed on the stock exchanges where the company's shares are already listed. Furthermore, the security certificates received for dematerialisation were mutilated and cancelled after verification, with the depositories' names substituted in the register of members as the registered owners within the prescribed timelines.

The company has requested that this information be taken on record.

Filing to action

What to do with a filing like this

Camlin Fine Sciences Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Camlin Fine Sciences Limited. Read the original for the full detail.

View original filing